Article Text
Abstract
Objective Heart failure (HF) prevalence rises sharply among those aged 85 years and over. Previous population based echocardiographic studies of left ventricular (LV) dysfunction, the substrate for HF, have included only small numbers in this age group. We used domiciliary echocardiography to estimate the prevalence of LV systolic and diastolic dysfunction in 87–89 year olds and the proportion remaining undiagnosed.
Design Cross sectional analysis of data from Newcastle 85+ Study.
Setting Primary care, North-East England.
Participants 376 men and women aged 87–89 years.
Measures Domiciliary echocardiography was performed and LV systolic and diastolic function was graded. The presence of limiting dyspnoea was assessed by questionnaire. Previous diagnoses of HF were abstracted from general practice (GP) records.
Results 32% of participants (119/376) had LV systolic dysfunction (ejection fraction (EF) ≤50%) and a further 20% (75/376) had moderate or severe LV diastolic dysfunction with preserved EF. Both echocardiographic assessment of LV function and dyspnoea status were available in 74% (278/376) of participants. Among these participants, limiting dyspnoea was present in approximately two thirds of those with significant (systolic or isolated moderate/severe diastolic) LV dysfunction. 84% (73/87) of participants with significant LV dysfunction and limiting dyspnoea did not have a pre-existing HF diagnosis in their GP records. Overall, 26% (73/278) of participants with both echocardiographic and dyspnoea data had undiagnosed, symptomatic, significant LV dysfunction.
Conclusion Significant systolic and diastolic LV dysfunction is much commoner in community dwelling 87–89 year olds than previous studies have suggested. The majority are both symptomatic and undiagnosed.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
Statistics from Altmetric.com
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement 1
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data Supplement 1 - Online Supplementary References
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data Supplement 1 - Online Supplementary References
Footnotes
FY and JC contributed equally to this manuscript.
Funding This work was supported by the British Heart Foundation (PG/08/026/24 712). The core Newcastle 85+ Study was supported by: UK Medical Research Council and Biotechnology and Biological Sciences Research Council (G0500997); Dunhill Medical Trust (R124/0509); and NHS North of Tyne (Newcastle Primary Care Trust). BK is supported by a British Heart Foundation Personal Chair. The funders had no role in the study design; in the collection, analysis or interpretation of the data; in the writing of the paper; or in the decision to submit the paper for publication. The work was supported by the UK NIHR Biomedical Research Centre for Age and Age Related Disease award to the Newcastle upon Tyne Hospitals NHS Foundation Trust.
Competing interests None.
Ethics approval The study was approved by the Newcastle and North Tyneside 1 research ethics committee (reference No 06/Q0905/2).
Provenance and peer review Not commissioned; externally peer reviewed.